457 results on '"SCHNEIDER, RAYFEL"'
Search Results
2. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis
3. Interleukin (IL)-1/IL-6-Inhibitor–Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses
4. Higher concentrations of vitamin D in Canadian children with juvenile idiopathic arthritis compared to healthy controls are associated with more frequent use of vitamin D supplements and season of birth
5. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis
6. Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
7. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis
8. Systemic Juvenile Idiopathic Arthritis
9. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
10. Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology
11. A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry
12. Lengthening sleep reduces pain in childhood arthritis: a crossover randomised controlled trial
13. “It’s Not Just About Getting Along”: Exploring Learning Through the Discourse and Practice of Interprofessional Collaboration
14. A curious case of growth failure and hypercalcemia: Answers
15. Pulmonary Involvement in the Systemic Inflammatory Diseases of Childhood
16. Contributors
17. Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey
18. A curious case of growth failure and hypercalcemia: Questions
19. Malnutrition in Juvenile Idiopathic Arthritis
20. Pediatric Rheumatology Collaborative Study Group – over four decades of pivotal clinical drug research in pediatric rheumatology
21. Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort
22. Development of neoplasms in pediatric patients with rheumatic disease exposed to anti-tumor necrosis factor therapies: a single Centre retrospective study
23. Contributors
24. Systemic Juvenile Idiopathic Arthritis
25. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort
26. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
27. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
28. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
29. ‘Getting to Know You’-Evaluation of a Formal Faculty Mentoring Program: OC4-4
30. Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial
31. Active Engagement of Adolescents with Chronic Diseases in Medical Education: Exploring Their Perceptions About Potential Contributions: CCME-OE5-4
32. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist
33. Additional file 1 of Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis
34. Chest CT findings in pediatric Wegener’s granulomatosis
35. Teaching the musculoskeletal examination in pediatrics: a scoping review
36. Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
37. Systemic juvenile idiopathic arthritis is associated with HLA-DRB1 in Europeans and Americans of European descent
38. Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
39. Chapter 3 Systemic Juvenile Idiopathic Arthritis
40. Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis – Two Ends of the Same Spectrum
41. Contributors
42. Pulmonary Involvement in the Systemic Inflammatory Diseases of Childhood
43. Characterization Of Changes In Gene Expression and Inflammatory Proteins In Systemic Juvenile Idiopathic Arthritis Patients On Canakinumab Therapy.: 1692
44. SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
45. CONTRIBUTORS
46. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood
47. Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
48. Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
49. Clinical and Psychosocial Stress Factors are Associated with Decline in Physical Activity Over Time in Children with Juvenile Idiopathic Arthritis
50. Comparing Apples to Apples in Post-COVID-Associated Multisystem Inflammatory Syndrome in Children (MIS-C)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.